Chart Trends®: Gout Report Highlights Differences Between Primary Care ... - PR Newswire (press release)

Chart Trends®: Gout Report Highlights Differences Between Primary Care ... PR Newswire (press release) Among new therapies in development for the treatment of gout, the most robust projections for use were associated with Ardea Biosciences' RDEA-594 compound. ... and more »

FOR THE FIRST TIME IN DECADES PATIENTS LIVING WITH GOUT HAVE NEW TREATMENT ... - Canada NewsWire (press release)

FOR THE FIRST TIME IN DECADES PATIENTS LIVING WITH GOUT HAVE NEW TREATMENT ... Canada NewsWire (press release) The underlying cause of gout is hyperuricemia, a condition of high levels of uric acid in the blood, and the key target in the treatment and management of ... and more »

Mind and Body - Joint effort! - The Hindu

The Hindu

Mind and Body - Joint effort! The Hindu ... scleroderma, juvenile rheumatoid arthritis, ankylosing spondylitis, gout, etc. Treatment has to be tailored to individual needs, lifestyle and health. ...

Prescription Drugs Effects of Unapproved Colchicine Effective But off Market ... - PrescriptionDrugs.com

Prescription Drugs Effects of Unapproved Colchicine Effective But off Market ... PrescriptionDrugs.com The majority of developing gout treatments remain unapproved because their prescription drugs effects have not yet met FDA standards, leaving few options ... and more »